In assessing the legal landscape within the U.S. regarding the contraceptive intrauterine device (IUD) Mirena, manufactured by Bayer AG, one of the most significant and newest areas of concern is allegations of an increased likelihood of cancer in breasts. This article, written from the U.S. product-liability law perspective explores the main concerns, developments since 2017 and […]